True and false positive rates for different criteria of evaluating statistical evidence from clinical trials

[1]  John P. A. Ioannidis,et al.  Bayes factors for superiority, non-inferiority, and equivalence designs , 2019, BMC Medical Research Methodology.

[2]  E. Wagenmakers,et al.  The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression in the US: A Bayesian meta-analysis of Food and Drug Administration reviews. , 2018, Journal of affective disorders.

[3]  Dimitris Fouskakis,et al.  Prior Distributions for Objective Bayesian Analysis , 2018, Bayesian Analysis.

[4]  J. Ioannidis,et al.  Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis , 2018, The Lancet.

[5]  L. Held,et al.  On p-Values and Bayes Factors , 2018 .

[6]  Richard D. Morey,et al.  Baysefactor: Computation of Bayes Factors for Common Designs , 2018 .

[7]  J. Ioannidis,et al.  A simulation study of the strength of evidence in the recommendation of medications based on two trials with statistically significant results , 2017, PloS one.

[8]  Christopher D. Chambers,et al.  Redefine statistical significance , 2017, Nature Human Behaviour.

[9]  J. Ioannidis,et al.  Evolution of Reporting P Values in the Biomedical Literature, 1990-2015. , 2016, JAMA.

[10]  George F Borm,et al.  The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method , 2014, BMC Medical Research Methodology.

[11]  B. Zaslavsky.  Bayesian Hypothesis Testing in Two‐Arm Trials with Dichotomous Outcomes , 2013, Biometrics.

[12]  John P A Ioannidis,et al.  Empirical evaluation of very large treatment effects of medical interventions. , 2012, JAMA.

[13]  Rafael Perera,et al.  New treatments compared to established treatments in randomized trials ( Review ) , 2022 .

[14]  M. J. Bayarri,et al.  Criteria for Bayesian model choice with application to variable selection , 2012, 1209.5240.

[15]  Ron D. Hays,et al.  The Concept of Clinically Meaningful Difference in Health-Related Quality-of-Life Research , 2012, PharmacoEconomics.

[16]  Ian F Tannock,et al.  When are "positive" clinical trials in oncology truly positive? , 2011, Journal of the National Cancer Institute.

[17]  R. Katz.  FDA: Evidentiary standards for drug development and approval , 2004, NeuroRX.

[18]  Sally Hopewell,et al.  The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed , 2010, BMJ : British Medical Journal.

[19]  Jeffrey N. Rouder,et al.  Bayesian t tests for accepting and rejecting the null hypothesis , 2009, Psychonomic bulletin & review.

[20]  R. Rosenthal,et al.  Selective publication of antidepressant trials and its influence on apparent efficacy. , 2008, The New England journal of medicine.

[21]  Bradley P Carlin,et al.  Practical Bayesian Design and Analysis for Drug and Device Clinical Trials , 2007, Journal of biopharmaceutical statistics.

[22]  A. Copay,et al.  Understanding the minimum clinically important difference: a review of concepts and methods. , 2007, The spine journal : official journal of the North American Spine Society.

[23]  Tony O’Hagan.  Bayes factors , 2006 .

[24]  J. Ioannidis.  Why Most Published Research Findings Are False , 2005 .

[25]  J. Woodcock,et al.  FDA senior management perspectives , 2005 .

[26]  J. Ioannidis.  Why Most Published Research Findings Are False , 2005, PLoS medicine.

[27]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[28]  Alan Cantor,et al.  The uncertainty principle and industry-sponsored research , 2000, The Lancet.

[29]  Steven Goodman.  Toward Evidence-Based Medical Statistics. 2: The Bayes Factor , 1999, Annals of Internal Medicine.

[30]  S. Goodman.  Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy , 1999, Annals of Internal Medicine.

[31]  Guidance for Industry Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products , 1998 .

[32]  S. Goodman,et al.  p values, hypothesis tests, and likelihood: implications for epidemiology of a neglected historical debate. , 1993, American journal of epidemiology.

[33]  H. Jeffreys.  The Theory of Probability , 1896 .